Malignant Hyperthermia
- 1 May 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (5) , 800-801
- https://doi.org/10.1001/archinte.1978.03630290082028
Abstract
A case of allergic rash associated with malignant hyperthermia (body temperature of 41 C) occurred in a patient who had been taking 400 mg of thioridazine hydrochloride (Mellaril) daily for two days. The condition responded well to supportive measures and immediate discontinuation of the drug use. (Arch Intern Med 138:800-801, 1978)This publication has 11 references indexed in Scilit:
- Some Observations on the Etiology of the Fulminant Hyperthermia—Stress SyndromePerspectives in Biology and Medicine, 1976
- Allergic Reaction to ThioridazineNew England Journal of Medicine, 1974
- Letter: Ventricular dysrhythmias and thioridazine in alcohol withdrawal.BMJ, 1973
- Thioridazine Pigmentary RetinopathyArchives of Ophthalmology (1950), 1973
- Massive Edema Induced by Thioridazine (Mellaril): An Unusual ComplicationJournal of the American Geriatrics Society, 1972
- Malignant hyperthermia: A statistical reviewCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1970
- Three cases of malignant hyperthermia with special consideration of managementCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1969
- BLOOD-DYSCRASIA AFTER THIORIDAZINEThe Lancet, 1965
- Agranulocytosis Associated With Thioridazine AdministrationJAMA, 1964
- GRANULOCYTE SUPPRESSION WITH THIORIDAZINE HYDROCHLORIDEJAMA, 1960